Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4799719

Cl.Cl.[Cl-].[H+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114618429-B Surface-modified ZSM-5 molecular sieve and application thereof 浙江蓝天环保高科技股份有限公司 2024-04-16 CN claimed
CN-115895039-A Triazine-based organic covalent skeleton-modified hydrotalcite-based flame retardant and preparation method thereof 湘潭大学 2023-04-04 CN claimed
CN-112758935-B Hydrogen circulation system for polycrystalline silicon production 中国恩菲工程技术有限公司 2022-09-30 CN claimed
CN-111936641-B Compositions and methods for detecting human papillomavirus 杭州诺辉健康科技有限公司 2022-07-15 CN claimed
CN-114618429-A Surface modification modified ZSM-5 molecular sieve and application thereof 浙江蓝天环保高科技股份有限公司 2022-06-14 CN claimed
CN-214456888-U Hydrogen circulation system for polycrystalline silicon production 中国恩菲工程技术有限公司 2021-10-22 CN claimed
CN-112758935-A Hydrogen circulation system for polycrystalline silicon production 中国恩菲工程技术有限公司 2021-05-07 CN claimed
CN-111936641-A Compositions and methods for detecting human papillomavirus 杭州诺辉健康科技有限公司 2020-11-13 CN claimed
CN-111304921-A Method for preparing super-lubricating anti-adhesion electrospun nanofiber membrane by one-step method 上海市伤骨科研究所 2020-06-19 CN claimed
JP-3086871-A None JP disclosed
CN-117897388-A BTK protein degradation agent 广州麓鹏制药有限公司 2024-04-16 CN disclosed
CN-114618429-B Surface-modified ZSM-5 molecular sieve and application thereof 浙江蓝天环保高科技股份有限公司 2024-04-16 CN disclosed
CN-115895039-A Triazine-based organic covalent skeleton-modified hydrotalcite-based flame retardant and preparation method thereof 湘潭大学 2023-04-04 CN disclosed
CN-115354086-A Compositions and methods for detecting human papillomavirus 杭州诺辉健康科技有限公司 2022-11-18 CN disclosed
US-20040004765-A1 Corner cube array and method of making the corner cube array SHARP KABUSHIKI KAISHA (JP) 2004-01-08 US disclosed
US-6620441-B1 By eliminating or at least sharply reducing the amount of alcohol impurity in the reaction mixture, products are formed which do not undergo the intolerable loss of active halogen content during the 10-day period ALBEMARLE CORPORATION 2003-09-16 US disclosed
US-20030124849-A1 Micro corner cube array, method of making the micro corner cube array, and display device SHARP KABUSHIKI KAISHA (JP) 2003-07-03 US disclosed
US-6310244-B1 DEMONSTRATES THE ABILITY TO WITHSTAND MANY COMMON REACTION CONDITIONS AND YET IS CLEAVABLE UNDER RELATIVELY MILD CONDITIONS. PHARMACOPEIA, INC. 2001-10-30 US disclosed
JP-H0386871-A SUBSTITUTED 2-IMINO-3-ALKYLBENZOTHIAZOLINE RHONE POULENC SANTE 1991-04-11 JP disclosed
US-4119624-A POLYESTERS IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1978-10-10 US disclosed